XML 54 R40.htm IDEA: XBRL DOCUMENT

Benefit Plans (Tables)

9 Months Ended

Jul. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):


			Three months Ended July 31,					Nine months Ended July 31,
			2021			2020		2021			2020
Cost of revenues		$	133		$	46		$	449		$	267
General and administrative expense			706			338			2,941			919
Research and development expense			33			6			97			40
		$	872		$	390		$	3,487		$	1,226

Summary of RSA and RSU Activity

The following table summarizes our RSA and RSU activity for the nine months ended July 31, 2021:


Restricted Stock Awards and Units			Shares		Weighted-Average Fair Value
Outstanding as of October 31, 2020			2,067,140		$	5.06
Granted - performance units			551,252			14.89
Granted - time-vesting restricted stock units			296,826			3.28
Vested			(221)			20.40
Outstanding as of January 31, 2021			2,914,997		$	5.46
Granted - time-vesting restricted stock units			37,550			11.05
Vested			(81,878)			13.13
Forfeited			(53,532)			10.86
Outstanding as of April 30, 2021			2,817,137		$	5.24
Granted - time-vesting restricted stock units			19,826			7.00
Vested			(835)			22.44
Forfeited			(170,364)			7.53
Outstanding as of July 31, 2021			2,665,764		$	5.10